Phase 2 trials used once-weekly subcutaneous injections ranging from 1 mg to 12 mg, with higher doses associated with greater weight reduction but more gastrointestinal side effects
Recognizing that each individuals journey is unique, our weight loss solutions take a personalized approach to address your specific needs and goals
Primarily triggered by food consumption, GLP-1 release occurs 10 15 minutes after eating
They open the door for change, but actively walking through that door is what makes the transformation last. The program is open to users with a BMI of 21 or higher
The quality seems top-notch, and I appreciate the fact that there is no bitter taste
They can reduce hunger, promote feelings of fullness, and slow gastric emptying, making it easier for patients to adhere to a healthy eating plan